Healthcare: China’s Biotech Revolution

We're moving over to a new show! Here's a sneak peek of what to expect when Motley Fool Money goes daily on January 5, 2022. Subscribe here on Spotify Subscribe here on Apple Podcasts 

Nick, Emily, Jason, and Dylan get together to talk through the companies they've learned the most from, the stocks they've sold recently (and why!) and also where you can catch all of them with The Motley Fool's new audio offering in 2022. Stocks: MELI, SHOP, GME, BBY Check out m ...  Show more

China is fast becoming a major player in the global pharmaceutical and biotech industries. Once focused primarily on generic and me-too drugs, Chinese companies are now making headlines with innovative breakthroughs in oncology and gene therapy. Foreign investors are taking notic ...  Show more

Our China Healthcare Analyst Jack Lin discusses how China’s biotech surge is reshaping healthcare, investment and innovation worldwide.Read more insights from Morgan Stanley.----- Transcript ----- Jack Lin: Welcome to Thoughts on the Market. I'm Jack Lin, from Morgan Stanley's Ch ...  Show more

Is this China’s renaissance? Despite a trade war with the United States, China seems to be bounding into a high-tech future, making moves diplomatically, militarily and technologically. But some Chinese regions are facing a weakening economy and the effects of rapid urbanisation. ...  Show more

Chinese President Xi Jinping's new slogan, "develop new productive forces," aims to bolster the expansion of high-tech sectors to drive economic growth. China already dominates the world of electric cars and controls more than 80 percent of the global solar panel manufacturing ma ...  Show more